Products for Research Use Only
RegisterLogin

Ordastobart

CAT: 0804-HY-P991336-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991336-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ordastobart (INBRX-106; ES-102) is a hexavalent OX40 agonist antibody. Ordastobart enhances OX40 receptor clustering, signaling, and downstream activation, thereby increasing the proliferation and activation of CD4+ and CD8+ T cells in vitro and in vivo. Ordastobart exhibits anti-tumor effects and improves survival in mouse models of cancer. Ordastobart is indicated for research in cancers such as fibrosarcoma and colorectal cancer[1].
CAS Number
2708115-83-5
Product Name Alternative
INBRX-106; ES-102
UNSPSC
12352203
Target
Orexin Receptor (OX Receptor)
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology
Purity
98
Smiles
[Ordastobart]
References & Citations
[1]Rowell E, et al. 856 INBRX-106: a novel hexavalent anti-OX40 agonist for the treatment of solid tumors[J]. Journal for ImmunoTherapy of Cancer, 2021, 9 (Suppl 2) : A897-A897.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
HW342236-01Research Grade ordastobart
GTR18776764-01Research Grade ordastobart Antibody
PX-TA2504-01Ordastobart Biosimilar - Research Grade

Popular Products